Skip to content
The Centers for Medicare & Medicaid Services (CMS) issued a directive telling private insurers providing Medicare Advantage (MA) plans to cover Biogen’s amyotrophic lateral sclerosis […]
CMS directs insurers to cover ALS drug Qalsody Read More »
The U.S. bioscience industry generated $3.2 trillion in overall output in 2023, according to the latest report from the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience
U.S. biotech generates $3.2 trillion in a year, report shows Read More »
Pictured above, Rep. Deborah Ross (D-NC) addresses the opening session of BIO’s Intellectual Property Counsels Committee Conference in Washington, D.C., on Nov. 18. The
BIO IP conference promotes protection of innovation Read More »
The U.S. Department of Agriculture (USDA) on Nov. 12 announced that biotech plants made through modifications that could have been achieved by conventional breeding can be
APHIS exempts more types of biotech plants from regulation Read More »
“We are seeing an ongoing lack of participation by diverse groups in trials,” said Wayne Frederick, M.D., MBA, President Emeritus of Howard University and
How clinical trial diversity is the path to health equity Read More »
Insurers and pharmacy benefit managers (PBMs) in search of profits are preventing patients from getting the drugs they need, according to the latest episode
How utilization management blocks patient access Read More »
As the world gathers in Baku, Azerbaijan, for the COP29 United Nations Climate Summit, the Biotechnology Innovation Organization (BIO) is ensuring biotech’s role in
BIO to present biotech’s benefits for climate and food at COP29 Read More »
Biotech apples designed to last longer, taste great, and make superior cider were the stars when Rep. Dan Newhouse (R-WA) toured Okanagan Specialty Fruits’
Rep. Newhouse: ‘Tremendous potential’ for biotech apples in U.S. food supply Read More »
Drugmakers dealing with the complex process of developing medicines must be allowed to decide against trying to bring a drug to market, the Biotechnology
Pictured, from left: Scott McMurray, Deputy Commissioner, Georgia Quick Start; Dave Penake, CEO, Saol Therapeutics; Margie Battle, Manager, Georgia BioScience Training Center; Megan Heaphy,
Rep. Hank Johnson and BIO tour biotech training facility in Atlanta Read More »
